Navigation Links
Catilin Receives Renewable Energy Award for Pilot Plant
Date:3/11/2009

Iowa Department of Economic Development Awards Funds to Catilin, Inc.

AMES, Iowa, March 11 /PRNewswire/ -- Catilin, Inc., a leading catalyst technology company for biofuels, announced today a Demonstration Fund award of $150,000 by the Iowa Department of Economic Development. The award is targeted for the upgrade of Catilin's biodiesel pilot plant, from batch to continuous operation mode. Operation of the pilot plant in the continuous mode is the final step in the rigorous commercialization process of the world's first heterogeneous (solid) biodiesel catalyst: Catilin's T300 Biodiesel Catalyst.

Biodiesel is commonly produced using a homogeneous (liquid) catalyst, such as sodium hydroxide or sodium methylate. These catalysts require excessive amounts of water, energy, toxic chemicals, and equipment to produce the biodiesel and glycerin co-products. Catilin's heterogeneous catalyst, on the other hand, does not suffer these traits and is also non-toxic, a critical issue throughout the U.S. and around the globe. Additionally, the T300 Catalyst can be used in existing plants with minimal modification as it reacts at common operational temperatures and pressure.

"We are pleased to receive the Iowa Demonstration Fund award. It validates our extensive and successful testing in our lab and now in our continuous process flow pilot plant. Our pilot plant produces 300,000 gallons of high-quality biodiesel per year utilizing Catilin's ground-breaking T300 Catalyst," said Larry Lenhart, Catilin President and CEO.

Catilin's pilot plant is located within the BECON (Biomass Energy Conversion) facility outside of Ames, IA. The pilot plant is open to visitors, prospective partners and customers.

About Catilin

Catilin, Inc. is a catalyst technology company that is revolutionizing biofuels production. Catilin has a unique, new technology for biodiesel production that greatly reduces the cost of producing a gallon of biodiesel while creating a superior quality biodiesel and glycerin by-product. Catilin's patent-pending, non-toxic technology is centered on a family of solid heterogeneous catalysts that can be easily utilized within existing production facilities, can be reused multiple times and works with virtually every biodiesel feedstock source.

The pioneering research of Catilin, in conjunction with Ames Laboratory and Iowa State University, continues to focus on the future of biodiesel, including the award-winning research on algae to biodiesel. Catilin is backed by Silicon Valley-based venture capital firms MDV-Mohr Davidow Ventures and Leader Ventures. For more information, please visit the website http://www.catilin.com

About the Demonstration Fund

In August 2007, the Legislature approved the creation of the Demonstration Fund through the Iowa Department of Economic Development to provide pre-seed capital grants of up to $150,000 to encourage prototype and concept development activities by small-and medium-sized Iowa companies in the advanced manufacturing, biosciences, and information technology industries. The fund is designed to encourage commercialization of innovation to foster competitive, profitable companies that create high paying jobs and wealth in Iowa. For more information, go to the website http://www.iowalifechanging.com/business/ic/demonstration_fund.html


'/>"/>
SOURCE Catilin, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Avon Protection Systems Receives NIOSH Approval for ST53 SCBA System
2. S*BIO Receives BioSpectrum Editors Choice, Emerging BioScience Company of Singapore Award
3. 3SBio Inc. Receives Official Recognition as a High-Tech Enterprise
4. AMPAC Fine Chemicals Receives the California Pollution Prevention Challenge Award Two Consecutive Years
5. Sinovac Receives GMP Certification for its New Filling and Packaging Production Facility
6. Advanced Life Sciences Receives Notice of Planned Cethromycin Review by FDA Advisory Committee
7. Serica Technologies Receives FDA 510(k) Clearance for SeriScaffold(TM) Technology for Soft Tissue Repair
8. Perceptive Informatics Receives Frost & Sullivan Product Line Strategy Award
9. IlluminOss Medical Receives ISO 13485 Certification
10. Sequella Receives SBIR Funding Grant from the NIH for Further Development of Tuberculosis Drug SQ609
11. NeoStem Receives Notice of Noncompliance from NYSE Alternext US
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... OTTAWA, ON (PRWEB) , ... June 23, 2016 , ... ... former DNA Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA ... joining the STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
(Date:6/23/2016)... June 23, 2016 ... 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 Published recently ... peer-reviewed journal from touchONCOLOGY, Andrew D Zelenetz ... of cancer care is placing an increasing burden ... expensive biologic therapies. With the patents on many ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, ... Pennsylvania Convention Center and will showcase its product’s latest features from June 26 ... presenting a scientific poster on Disrupting Clinical Trials in The Cloud during the ...
Breaking Biology Technology:
(Date:6/2/2016)... 2, 2016   The Weather Company , an IBM ... an industry-first capability in which consumers will be able to ... ask questions via voice or text and receive relevant information ... Marketers have long sought an advertising solution that ... be personal, relevant and valuable; and can scale across millions ...
(Date:5/24/2016)... 2016 Ampronix facilitates superior patient care by providing unparalleled technology to leaders ... is the latest premium product recently added to the range of products distributed by ... ... ... LCD Medical Display- Ampronix News ...
(Date:5/12/2016)... WearablesResearch.com , a brand of Troubadour ... from the Q1 wave of its quarterly wearables survey. ... receptivity to a program where they would receive discounts ... company. "We were surprised to see that ... LaColla , CEO of Troubadour Research, "primarily because there ...
Breaking Biology News(10 mins):